CENTENE CORP News
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. It operates in two segments, Managed Care and Specialty Services. The Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, long-term services and support, foster care, and medicare-medicaid plans, which cover dually eligible individuals, as well as aged, blind, or disabled programs. This segment also provides a variety of individual, small group, and large group commercial healthcare products to employers and members. This segment also offers various individual, small group, and large group commercial healthcare products to employers and members. The Specialty Services segment offers behavioral health and employee assistance plans; clinical healthcare, primary care, various specialty services, and a suite of social and other support services; data analytics solutions; administrative services to Military Health System eligible beneficiaries; traditional pharmacy clinical and administrative services as well as specialized pharmacy benefit services through its specialty pharmacy business; and vision and dental health services. This segment provides auxiliary healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations; and engages in the government contracts business under the TRICARE program and other healthcare related government contracts. The company provides its services through primary and specialty care physicians, hospitals, and ancillary providers. Centene Corporation was founded in 1984 and is headquartered in St. Louis, Missouri.
see moreCENTENE CORP Market News
5d
Centene Surges After Strong Q1 Beat & Guidance
- Centene (CNC) beat Q1 expectations with $3.37 adjusted EPS, raised full-year guidance, repurchased $1B of debt and reported strong operating cash flow — driving analyst upgrades and a sharp stock rally while enrollment declines remain a watch item.
23 Mar at 04:19
Centene Faces CMS Crackdown and Value-Based Upside
Recent CMS enforcement actions — a DME enrollment moratorium, withheld Medicaid funds, and tighter price-reporting rules — raise near-term compliance risk for Centene (CNC) while expansion of the ACCESS value-based model offers strategic upside. This article explains the direct implications for Centene’s operations, margins, and investor outlook.
02 Mar at 04:17
Centene Q4 Fallout: Loss, Guidance, Strategy Shift
Centene reported a $1.1B Q4 loss but beat revenue expectations and issued 2026 guidance above $3 EPS. Membership shifts, Medicare Advantage exits, rising costs, and an AI push frame the near-term recovery story for CNC.
23 Feb at 04:17
Centene Drops After Minimal CMS Medicare Increase.
Centene (CNC) weakened this week after CMS proposed a nominal 0.09% increase to 2027 Medicare Advantage payments. The muted guidance sent insurers lower, leaving Centene underperforming peers such as Molina amid persistent reimbursement pressure and margin concerns.
16 Feb at 04:17
Centene Slides After CMS Rates Volatile Week Ahead
Centene (CNC) saw sharp short-term swings this week after CMS proposed a near-flat Medicare Advantage rate update for 2027. A midweek selloff and rebound — combined with elevated trading volume and mixed analyst responses — underline policy-driven margin risk for the insurer and spotlight the stock's sensitivity to healthcare payment decisions.